Prostate Cancer Market Research Reports

Prostate Cancer Market Research

Incidences of cancer afflictions have rapidly increased in recent years, while efforts are still underway to find a ... view more

RSS Sort By :
TITLE Price Buy Now More options

In this report, the United States Prostate Cancer Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this repo...

$ 3800


"The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous ...

$ 4480


In this report, the global Prostate Cancer Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report spli...

$ 4000


DelveInsight “Prostate cancer - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Prostate cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical a...

$ 2750


In this report, the global Prostate Cancer Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is s...

$ 2900


DelveInsight’s, “Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Metastatic Hormone Refractory Prostate Cancer. The report provi...

$ 1500


DelveInsight’s, Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Metastatic Hormone Refractory...

$ 2000


DelveInsight’s, Metastatic Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Metastatic Prostate Cancer. The report includes ...

$ 2000


DelveInsight’s “Metastatic Hormone Refractory Prostate Cancer -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Metastatic Hormone Refractory Prostate Cancer in seven major markets (US, France, Germany, Italy, Spain, UK...

$ 2950


DelveInsight’s “Metastatic Prostate Cancer -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Metastatic Prostate Cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epid...

$ 2950


DelveInsight’s “Prostate cancer - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Prostate cancer - Market In...

$ 5750


DelveInsight’s “Metastatic Hormone Refractory Prostate Cancer - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Metastatic Hormone Refractory Prostate Cancer for th...

$ 5750


DelveInsight’s “Metastatic Prostate Cancer - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Metastatic Prostate Cancer for the 7MM (United States, Germany, France,...

$ 5750


This report studies the global Prostate Cancer Therapeutics Drugs market, analyzes and researches the Prostate Cancer Therapeutics Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses...

$ 3300


This report studies Prostate Cancer Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 202...

$ 3500


Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, “Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an ...

$ 4000


This report studies Prostate Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast ...

$ 3500


“Global liquid biopsy market projected to grow at a CAGR of 23.4%” The global liquid biopsy market is estimated to grow at a CAGR of 23.4% from 2017 to 2022, to reach USD 2,047.9 million by 2022. Increasing pre...

$ 5650


Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, Androgen-Inde...

$ 2500


Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, “Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Ho...

$ 2500

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: